Academia-pharma partnerships have long been a driving force for scientific innovation, and both sides bring distinct, complementary strengths to the table. Know how expertise, assets and platforms need to be leveraged and bridged across the collaborating partners to create additional value and translate towards tangible solutions. How is this best fostered? What concrete outcomes can cross-fertilisation deliver in these partnerships? How and what can the partners learn from one another? This session will explore how complementary strengths and expertise translate into measurable deliverables and long-term impact for both sectors, ultimately benefitting society and patients.
Yao Cheng
Associate Director, External Research Collaborations
Novartis
